ObsEva SA (OBSEF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Aug 19, 2026
ObsEva Market Cap
ObsEva has a market cap or net worth of $11.72 thousand as of August 20, 2026.
Market Cap
11.72K
Enterprise Value
n/a
Revenue
19.64M
Ranking
n/a
PE Ratio
0.00
Stock Price
$0.00
ChartMarket Cap Chart
Since January 26, 2017, ObsEva's market cap has decreased from 324.44M to 11.72K, a decrease of -100.00%. That is a compound annual growth rate of -65.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 11.72K | - |
| Dec 31, 2025 | 11.72K | - |
| Dec 31, 2024 | 11.72K | -99.71% |
| Dec 29, 2023 | 4.10M | -77.39% |
| Dec 30, 2022 | 18.14M | -88.83% |
| Dec 31, 2021 | 162.34M | 27.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 26, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scopus BioPharma | 16.83K |
| Regenicin | 15.35K |
| NanoLogix | 13.03K |
| Vaxxinity | 12.68K |
| NovAccess Global | 12.33K |
| Biostax | 10.77K |
| Syros Pharmaceuticals | 10.73K |
| GeneLink | 10.60K |